These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24524884)

  • 1. Current uses of botulinum toxin A as an adjunct to hand therapy interventions of hand conditions.
    Kalliainen LK; O'Brien VH
    J Hand Ther; 2014; 27(2):85-94; quiz 95. PubMed ID: 24524884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of botulinum toxin type A in the management of adult-onset focal spasticity: a survey of Australian allied health professionals.
    Williams G; Olver J; de Graaff S; Singer BJ
    Aust Occup Ther J; 2012 Aug; 59(4):257-64. PubMed ID: 22934898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin A (Dysport®): in dystonias and focal spasticity.
    Keam SJ; Muir VJ; Deeks ED
    Drugs; 2011 May; 71(8):1043-58. PubMed ID: 21668041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin physiology in focal hand and cranial dystonia.
    Karp BI
    Toxins (Basel); 2012 Nov; 4(11):1404-14. PubMed ID: 23202323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal spasticity therapy with botulinum toxin: effects on function, activities of daily living and pain in 100 adult patients.
    Bergfeldt U; Borg K; Kullander K; Julin P
    J Rehabil Med; 2006 May; 38(3):166-71. PubMed ID: 16702083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin A--effect on spasticity].
    Smedal T; Gjelsvik B; Lygren H; Borgmann R; Waje-Andreassen U; Grønning M
    Tidsskr Nor Laegeforen; 2001 Nov; 121(28):3277-80. PubMed ID: 11826458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper limb spasticity management for patients who have received Botulinum Toxin A injection: Australian therapy practice.
    Cusick A; Lannin N; Kinnear BZ
    Aust Occup Ther J; 2015 Feb; 62(1):27-40. PubMed ID: 25649033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Focal dystonias and their treatment with dysport (botulinum toxin type A)].
    Orlova OR; Timerbaeva SL; Khat'kova SE; Kotliarov VV; Korenko LA; Zalialova ZA; Fal'kovskiĭ IV; Shperling LP; Antipova LN; Antipenko EA; Mingazova LR; Soĭkher MI; Krasavina DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):81-9. PubMed ID: 22951787
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in active range of motion measurements in the upper extremity of patients with writer's cramp compared with healthy controls.
    Srivanitchapoom P; Shamim EA; Diomi P; Hattori T; Pandey S; Vorbach S; Park JE; Wu T; Auh S; Hallett M
    J Hand Ther; 2016; 29(4):489-495. PubMed ID: 27773588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of botulinum A toxin (BOTOX) in different types of facial dystonia.
    Shoaib KK; Inam-ul-Haq ; Khan MD
    J Coll Physicians Surg Pak; 2009 Nov; 19(11):742-3. PubMed ID: 19889277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular injection of botulinum toxin as an adjunct to total joint replacement in temporomandibular joint ankylosis: preliminary reports.
    Robiony M
    J Oral Maxillofac Surg; 2011 Jan; 69(1):280-4. PubMed ID: 21055863
    [No Abstract]   [Full Text] [Related]  

  • 14. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Applications of botulinum toxin in Neurology].
    Garcia-Ruiz PJ
    Med Clin (Barc); 2013 Jul; 141(1):33-6. PubMed ID: 23434466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
    Calne S
    Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystonia, botulinum neurotoxin, and the aviator.
    Feinberg MJ
    Aviat Space Environ Med; 1999 Dec; 70(12):1235-7. PubMed ID: 10596783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes.
    Hubble J; Schwab J; Hubert C; Abbott CC
    Clin Neuropharmacol; 2013; 36(4):122-7. PubMed ID: 23783005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.